European regulators gave Bio-Rad Laboratories CE-IVD marking for its QXDx BCR-ABL %IS Kit, a droplet digital PCR assay intended for the detection of BCR-ABL gene fusions. The test, which provides absolute quantification and scalable throughput from eight to 48 samples per run, can facilitate monitoring of response to treatment in chronic myeloid leukemia patients.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.